Please ensure Javascript is enabled for purposes of website accessibility

Psychedelic Breakthrough: MDMA Revolutionizes PTSD Treatment


Psychedelic therapies, including the use of MDMA, are set to revolutionize psychiatric treatments, especially for those with post-traumatic stress disorder (PTSD).

The anticipation builds for the FDA’s approval of MDMA-assisted therapy for PTSD, which will mark a first for a psychedelic drug in mainstream medicine. MDMA’s potential extends to patients with multiple or treatment-resistant disorders, particularly those who concurrently suffer from PTSD and substance use disorder (SUD).

Learn More: